Eribulin FDA approval date

The FDA approved Eribulin (Halaven) on 15 Nov 2010.

FDA approval date
15 Nov 2010

Drug identity checked against registry records

Also recorded as Halaven

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2010-11-15DayEribulinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA201532", "applicant_as_listed_by_fda": "EISAI INC", "brand_names": ["HALAVEN"], "active_ingredients": ["ERIBULIN MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20101115", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026